Literature DB >> 476597

Chemotherapy for adenocarcinoma of the lung with 5-fluorouracil, cyclophosphamide, and CCNU (FCC).

A Y Bedikian, R Staab, R Livingston, M Valdivieso, M A Burgess, G P Bodey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 476597     DOI： 10.1002/1097-0142(197909)44:3<858::aid-cncr2820440310>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

Review 1.  Combination chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lung.

Authors:  R E Taylor; I E Smith; H T Ford; B M Bryant; A J Casey; J F Smyth
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Chemotherapy of lung cancer.

Authors:  R J Papac
Journal:  Yale J Biol Med       Date:  1981 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.